Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial

Autor: Nugent, Francis W.1,2,3,4,5 francis.nugent@usoncology.com, Mertens, Wilson C.1,2,3,4,5, Graziano, Stephen1,2,3,4,5, Levitan, Nathan1,2,3,4,5, Collea, Rufus1,2,3,4,5, Gajra, Ajeet1,2,3,4,5, Marshall, Janine1,2,3,4,5, McCann, John1,2,3,4,5
Zdroj: Lung Cancer (01695002). May2005, Vol. 48 Issue 2, p267-273. 7p.
Databáze: Academic Search Ultimate
Externí odkaz: